Royalty Pharma (RPRX) Shares Repurchased (2019 - 2025)
Royalty Pharma (RPRX) has disclosed Shares Repurchased for 4 consecutive years, with $80.5 million as the latest value for Q4 2025.
- Quarterly Shares Repurchased rose 53.09% to $80.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, up 434.46% year-over-year, with the annual reading at $1.2 billion for FY2025, 434.46% up from the prior year.
- Shares Repurchased hit $80.5 million in Q4 2025 for Royalty Pharma, down from $146.5 million in the prior quarter.
- In the past five years, Shares Repurchased ranged from a high of $708.8 million in Q1 2025 to a low of $30.2 million in Q4 2023.
- Historically, Shares Repurchased has averaged $180.8 million across 3 years, with a median of $97.0 million in 2024.
- Biggest five-year swings in Shares Repurchased: tumbled 30.74% in 2024 and later soared 264.47% in 2025.
- Year by year, Shares Repurchased stood at $30.2 million in 2023, then skyrocketed by 74.2% to $52.6 million in 2024, then soared by 53.09% to $80.5 million in 2025.
- Business Quant data shows Shares Repurchased for RPRX at $80.5 million in Q4 2025, $146.5 million in Q3 2025, and $291.6 million in Q2 2025.